Bristol Myers Squibb (BMY)

R&D to Revenue

22.81%

Quarterly · Period ending:

BMY logo

BMY R&D to Revenue

Latest reported22.81%
BMY Quarterly R&D/Revenue (0.00% → 22.81%)
High-resolution chart · PNG

BMY r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D to Revenue — Quarterly
Period endingR&D to Revenue
10.5118%
10.8339%
11.7893%
10.4975%
8.9479%
8.4791%
9.5229%
8.5516%
9.2073%
8.7145%
8.434%
8.7995%
8.6682%
8.6145%
8.8268%
8.3353%
7.8986%
8.0593%
8.2933%
8.972%
8.3604%
8.2311%
8.9523%
8.5848%
8.5341%
8.7852%
9.298%
9.3452%
9.1246%
9.2096%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.